In Segment A, individuals will acquire various doses and schedules of oral ABBV-744 tablet to detect Risk-free dosing program. Extra members might be enrolled at the determined monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section C, individuals https://quentinl777coz1.thekatyblog.com/profile